| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/25/2001 | EP1093519A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | CN1292827A Nucleic acid transfer vectors, compositions containing same and uses |
| 04/25/2001 | CN1292820A i (Neisseria meningitidis) antigens |
| 04/24/2001 | US6222027 Molecules expressed in hippocampus |
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222025 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom |
| 04/24/2001 | US6222022 Amino acid sequences of protein related to glial-derived neurotrophic factor and neurturin; diagnosis and treatment of alzheimer's/parkinson's/huntington's diseases, strokes, brain and spinal chord injuries, amyotrophic lateral sclerosis |
| 04/24/2001 | US6222018 Antibody which binds to transcription factor; for detection in samples; for screening expression libraries |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221959 Polynucleotide, polymer complex |
| 04/24/2001 | US6221850 For detecting and modulating levels of jun n-terminal kinases (jnk proteins), enzymes which are encoded by jnk genes. |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221848 In vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject; preventing esophagitis during treatment of lung cancer patients with ionizing radiation and/or chemotherapy |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221643 Methods for diagnosis and treatment of Bloom's syndrome |
| 04/24/2001 | US6221631 tktA |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221362 A vaccine formula allowing the vaccination of avian species, in particular chickens. |
| 04/24/2001 | US6221352 Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells |
| 04/24/2001 | US6221349 Adeno-associated vectors for expression of factor VIII by target cells |
| 04/19/2001 | WO2001027334A2 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027303A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | WO2001027302A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027281A1 Designing immunogens |
| 04/19/2001 | WO2001027276A2 Dna sequences from breast tumor and uses thereof |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027272A1 Oculomedin and glaucoma |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027262A1 Gene selection using pnas |
| 04/19/2001 | WO2001027256A2 Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027249A1 Novel gene encoding a dna methyltransferase, dnmt3l |
| 04/19/2001 | WO2001027243A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 04/19/2001 | WO2001027157A1 A biologically active complex of nr6 and cardiotrophin-like-cytokine |
| 04/19/2001 | WO2001027156A1 Interleukin-2 like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027154A2 Membrane translocating peptide drug delivery system |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001026694A1 Gene therapy for cardiomyopathy |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026679A2 T-cells and molecules involved in immune regulation |
| 04/19/2001 | WO2001026672A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | WO2001026667A1 Tenocyte compositions and production and uses thereof |
| 04/19/2001 | WO2001026643A1 Inhibition of tumorigenic properties of melanoma cells |
| 04/19/2001 | WO2001026629A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026628A1 Cationic dosper virosomes |
| 04/19/2001 | WO2001026625A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2000078986B1 Regulation system of expression using nuclear ppar receptors |
| 04/19/2001 | WO2000077232A8 Promoters from atlantic salmon |
| 04/19/2001 | WO2000071078A3 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 04/19/2001 | WO2000070086A9 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000067762A3 Selenium-containing pro-drugs for cancer therapy |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000029589A9 Methioninase gene therapy for tumor treatment |
| 04/19/2001 | WO1999064566A3 In vitro maintenance of hematopoietic stem cells |
| 04/19/2001 | WO1999056785A3 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction |
| 04/19/2001 | WO1999051188A3 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 04/19/2001 | DE19947668A1 Tumorspezifischer Vektor für die Gentherapie A tumor-specific vector for gene therapy |
| 04/19/2001 | CA2388053A1 Cationic dosper virosomes |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387355A1 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/19/2001 | CA2386177A1 Oculomedin and glaucoma |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385186A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092777A1 Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| 04/18/2001 | EP1092771A2 Tetracycline-regulated transcriptional modulators |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092436A1 Tenocyte compositions, preparation and use |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1091762A1 Transgene expression in polarized cells |
| 04/18/2001 | EP0796240B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 04/18/2001 | EP0671923B1 Liver reserve cells |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291899A Live recombined vaccines injected with adjuvant |